rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2010-3-4
|
pubmed:abstractText |
On the basis of the superimposition of the crystal structures of norindenoisoquinoline 5 and topotecan (2) bound in the topoisomerase I-DNA covalent complex, as well as molecular docking and quantum chemical calculations, the substituted norindenoisoquinoline 14a was designed by transporting the 9-dimethylaminomethyl group of topotecan to the 10-position of the norindenoisoquinoline 5. The desired compound 14a was synthesized and found to possess topoisomerase I inhibitory activity that was slightly better than that of the starting compound 5. A focused set of 10-substitued norindenoisoquinoline analogues were then synthesized. The imidazole-substituted compound 14c was highly cytotoxic when evaluated in a series of human leukemia, ovarian, and breast cancer cells.
|
pubmed:grant |
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-11020283,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-11261892,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-11280753,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-11395412,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-11895891,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-12426403,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-12852757,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-14667224,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-15203138,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-15509164,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-15801827,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-16033260,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-16308697,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-16309825,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-16442283,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-16505102,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-16750365,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-16842195,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-16913702,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-16990856,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-16990858,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-17034134,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-17181156,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-17402722,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-17676830,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-17696418,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-17974983,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-18061144,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-18636761,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-19476377,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-2832051,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-5030802,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-7882333,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-8272406,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-8289200,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-9139114,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-9658189,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-9748515,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20155916-9986716
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1520-4804
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
11
|
pubmed:volume |
53
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1979-89
|
pubmed:dateRevised |
2011-7-26
|
pubmed:meshHeading |
pubmed-meshheading:20155916-Antineoplastic Agents,
pubmed-meshheading:20155916-Cell Line, Tumor,
pubmed-meshheading:20155916-Cell Proliferation,
pubmed-meshheading:20155916-Drug Design,
pubmed-meshheading:20155916-Enzyme Inhibitors,
pubmed-meshheading:20155916-Humans,
pubmed-meshheading:20155916-Indenes,
pubmed-meshheading:20155916-Isoquinolines,
pubmed-meshheading:20155916-Magnetic Resonance Spectroscopy,
pubmed-meshheading:20155916-Models, Molecular,
pubmed-meshheading:20155916-Spectrometry, Mass, Electrospray Ionization,
pubmed-meshheading:20155916-Structure-Activity Relationship,
pubmed-meshheading:20155916-Thermodynamics,
pubmed-meshheading:20155916-Topoisomerase I Inhibitors
|
pubmed:year |
2010
|
pubmed:articleTitle |
Structure-based design, synthesis, and biological studies of new anticancer norindenoisoquinoline topoisomerase I inhibitors.
|
pubmed:affiliation |
Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmaceutical Sciences, and the Purdue University Center for Cancer Research, Purdue University, West Lafayette, Indiana 47907, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|